Vachon M G, Nairn J G
Faculty of Pharmacy, University of Toronto, Ontario, Canada.
J Microencapsul. 1995 May-Jun;12(3):287-305. doi: 10.3109/02652049509010297.
Controlled release homogeneous matrix microspheres containing acetylsalicylic acid (ASA) were prepared by a simple mechanical process using Eudragit RS100 as the matrix polymer. A drug-polymer solution in a binary solvent of methylene chloride/acetone (9:1) was prepared and infused at a rate of 15 microliters/min as small droplets into a flowing stream of mineral oil where partition of the solvent occurred. A series of experiments was conducted in which the polymer to drug ratio in the infusion solution was fixed at 5:1, 4:1, 3:1 or 2:1 while varying the infusion solution viscosity by altering the infusion solution total solids concentration. Results indicate that microsphere mean particle size was maintained at 200-300 microns once the infusion solution viscosity exceeded 2 cps. The physical state of the ASA incorporated into the microspheres, as confirmed by SEM and thermal analysis, was amorphous in nature until a drug loading of 24% was reached. Drug loading for each polymer to drug ratio increased in a proportional manner with respect to the initial drug concentration of the infusion solution. Dissolution release profiles were found to be biphasic and best analysed according to the semi-empirical equation of Ritger-Peppas, Mt/Mx = k2tn, for the initial phase and by the square-root model of Higuchi, Qt = k1t1/2 for the latter phase. This difference was attributed to the lack of a barrier effect to the drug diffusion process during the latter dissolution phase when the microspheres are fully hydrated.
以Eudragit RS100为基质聚合物,通过简单的机械工艺制备了含乙酰水杨酸(ASA)的控释均匀基质微球。制备了二氯甲烷/丙酮(9:1)二元溶剂中的药物 - 聚合物溶液,并以15微升/分钟的速率作为小液滴注入流动的矿物油流中,在其中发生溶剂分配。进行了一系列实验,其中输注溶液中聚合物与药物的比例固定为5:1、4:1、3:1或2:1,同时通过改变输注溶液的总固体浓度来改变输注溶液的粘度。结果表明,一旦输注溶液粘度超过2厘泊,微球平均粒径保持在200 - 300微米。通过扫描电子显微镜(SEM)和热分析证实,掺入微球中的ASA的物理状态在达到24%的载药量之前本质上是无定形的。每种聚合物与药物比例的载药量相对于输注溶液的初始药物浓度成比例增加。发现溶出释放曲线是双相的,对于初始阶段,根据Ritger - Peppas的半经验方程Mt/Mx = k2tn进行最佳分析,对于后一阶段,根据Higuchi的平方根模型Qt = k1t1/2进行分析。这种差异归因于在后一溶出阶段微球完全水合时对药物扩散过程缺乏屏障作用。